The Roles of MDM2 and MDMX in Cancer

Orit Karni-Schmidt1, Maria Lokshin1, Carol Prives1

  • 1Department of Biological Sciences, Columbia University, New York, NY 10027;

Insights

MDM2 and MDMX proteins promote cancer by inhibiting the p53 tumor suppressor. Understanding their roles in cancer may lead to new diagnostic and therapeutic strategies targeting these oncogenic proteins.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MDM2 and MDMX (MDM4) are oncogenic proteins with over 25 years of research.
  • They primarily function as negative regulators of the p53 tumor suppressor protein.
  • Potential p53-independent roles in tumorigenesis are also being investigated.

Purpose of the Study:

  • To explore the dysregulation of MDM2 and MDMX in human cancers.
  • To elucidate their distinct and collaborative roles in tumorigenesis.
  • To identify potential diagnostic and prognostic biomarkers and therapeutic targets.

Main Methods:

  • Review of existing literature on MDM2, MDMX, and p53 interactions in cancer.
  • Analysis of cancer genomics data to identify dysregulation patterns.
  • Functional studies investigating oncogenic mechanisms.

Main Results:

  • MDM2 and MDMX are frequently dysregulated in various human cancers.
  • Both proteins contribute to oncogenesis through p53 inhibition and potentially other pathways.
  • Their combined or individual actions are critical in tumor development.

Conclusions:

  • Understanding MDM2 and MDMX functions is crucial for cancer diagnosis and prognosis.
  • Targeting MDM2, MDMX, or their regulators presents a promising therapeutic avenue for cancer treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.8K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

3.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.2K